Synteract Inc. Announces New Vice President of Medical and Regulatory Affairs

Sep 13, 2004, 01:00 ET from Synteract Inc.

    SAN DIEGO, Sept. 13 /PRNewswire/ -- Dr. Marilyn R. Carlson has joined
 Synteract as the Vice President of Medical & Regulatory Affairs, providing
 senior executive medical and regulatory guidance to the Company's clients.
     Dr. Carlson is a graduate of Harvard (D.M.D.) and Case Western Reserve
 University (M.D.).  She completed Internal Medicine at the Cleveland Clinic
 and is certified in Regulatory Affairs.
     "We are fortunate to have a person of Dr. Carlson's caliber join our
 Organization.  She brings over 13 years of pharmaceutical field experience to
 Synteract having worked across multiple therapeutic areas in the
 biotechnology, pharmaceutical, pharmacogenomic, medical device and managed
 care industries," said Ellen Morgan, President and Chief Executive Officer of
 Synteract, Inc.  "Her knowledge and expertise in Medical, Regulatory and
 Clinical Affairs will be a valuable resource for Synteract's rapid growth and
 will expand the medical and regulatory services Synteract provides for their
 clients, particularly in early phase studies and overall strategic clinical
 program planning."
     Dr. Carlson was previously with Procter & Gamble, XOMA, ISTA
 Pharmaceuticals and Prometheus Laboratories.  She is President of entreMeDica,
 Inc., a medical consulting company.
     About Synteract Inc.
     Established in 1995, Synteract is a privately held, full-service contract
 research organization, dedicated to meeting the various needs of
 biotechnology, biomedical, pharmaceutical, and drug industry firms.  Based in
 Carlsbad, CA, with a branch office in Pennsylvania, the Company provides
 expertise in a wide range of therapeutic areas and maintains a wealth of
 knowledge in oncology, ophthalmology, HIV, sexual dysfunction, cardiovascular
 disease, and pain.  Since 2000, it has been a key development shop for web,
 wireless and voice data solutions that speed the completion of clinical trials
 and assist in access to clinical trials information.  This includes
 technologies such as electronic data capture (EDC), interactive voice response
 systems (IVRS), and automated safety tracking and reporting.  For information,
 please visit us at or call (760) 268.8200.
     For more information please contact: Ellen Morgan, +1-760-268-8200

SOURCE Synteract Inc.